Cycling strategies and break protocols The GHK-Cu discontinuation profile suggesting gradual benefit decline without rebound effects creates opportunity for cycling strategies potentially offering benefits including reduced long-term cost through intermittent rather than continuous product purchase, decreased skin adaptation risk by preventing tolerance to copper peptide stimulation, improved treatment responsiveness when restarting after breaks allowing periodic benefit surges, and psychological flexibility avoiding dependency mindset from continuous indefinite use requirements
Adinolfi S, Patinen T, Jawahar Deen A, Pitknen S, Hrknen J, Kansanen E, et al
How to dose peptides for beginners
However, oxidative stress and associated decreases in levels of glutathione (GSH) are known to play a central role in ALD
Our clinician sources compounds from licensed pharmaceutical compounders, ensuring purity and consistency with every treatment
No direct trial evidence No published clinical trial has evaluated the four-peptide KLOW combination together, and the doses cited above are extrapolated from individual-component research and community protocols, not validated as a synergistic dose for the blend